Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial
Författare
Publiceringsår
2009
Språk
Engelska
Sidor
221-221
Publikation/Tidskrift/Serie
Blood
Volym
114
Issue
22
Dokumenttyp
Konferensbidrag: abstract
Förlag
American Society of Hematology
Ämne
- Hematology
Conference name
51st Annual Meeting of the American-Society-of-Hematology
Conference date
2009-12-05 - 2009-12-08
Status
Published
ISBN/ISSN/Övrigt
- ISSN: 1528-0020